Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126936811 | 12693681 | 1 | I | 20160824 | 20160829 | 20160829 | EXP | GB-MHRA-EYC 00144005 | GB-009507513-1608GBR012207 | MERCK | 55.00 | YR | F | Y | 54.00000 | KG | 20160829 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126936811 | 12693681 | 1 | PS | EZETIMIBE. | EZETIMIBE | 1 | Oral | 10 MG, UNK | N | U | 21445 | 10 | MG | TABLET | |||||
| 126936811 | 12693681 | 2 | I | ROSUVASTATIN. | ROSUVASTATIN | 1 | Oral | 20 MG, UNK | N | U | 0 | 20 | MG | ||||||
| 126936811 | 12693681 | 3 | C | CALCEOS | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 0 | POWDER |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126936811 | 12693681 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126936811 | 12693681 | Acute kidney injury | |
| 126936811 | 12693681 | Drug interaction | |
| 126936811 | 12693681 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |